COMMUNIQUÉS West-GlobeNewswire

Cambrex to Present at the Jefferies 2018 Global Healthcare Conference
01/06/2018
EAST RUTHERFORD, N.J., June 01, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]
ZoomMed and KDA Group Join Forces to Distribute the ZRx Prescriber in the United States
01/06/2018
MONTREAL, June 01, 2018 (GLOBE NEWSWIRE) -- ZoomMed Inc . (the “Corporation” or “ZoomMed”) (TSX Venture Exchange:ZMD) and KDA Group Inc . (“KDA”) (TSX Venture Exchange:KDA) are proud to announce an agreement whereby [...]
ZoomMed et Groupe KDA unissent leurs efforts pour la distribution du Prescripteur ZRx aux États-Unis
01/06/2018
MONTRÉAL, 01 juin 2018 (GLOBE NEWSWIRE) -- ZoomMed Inc. (la « Société » ou « ZoomMed ») (Bourse de Croissance TSX:ZMD) et Groupe KDA Inc. (« KDA ») (Bourse de Croissance TSX:KDA) sont fiers d’annoncer la signature d’un [...]
Trading in Coloplast shares by board members, executives or associated persons
01/06/2018
Nasdaq Copenhagen 1 June 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on the [...]
Trading in Coloplast shares by board members, executives or associated persons
01/06/2018
Nasdaq Copenhagen 1 June 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation art. 19 Coloplast is obliged to report on the [...]
Vistin Pharma ASA : Completion of subsequent repair issue, registration of share capital increase
01/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Oncolytics Biotech® Prices USD $8,000,000 Million Public Offering of Common Shares
01/06/2018
CALGARY, Alberta and SAN DIEGO, June 01, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX:ONC) (NASDAQ:ONCY), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
Canada House Wellness Group Continues Strategic Transformation with Appointment of New Chief Executive Officer and Change to Board of Directors
01/06/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 01, 2018 (GLOBE NEWSWIRE) -- The Board of Directors of Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or [...]
Lundbeck and Otsuka’s Rxulti® (brexpiprazole) receives positive opinion in EU from CHMP for the treatment of schizophrenia in adults
01/06/2018
Press release Valby, 1 June 2018 A final decision from the European Commission is expected within 67 days. H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that the Committee for [...]
CV Sciences, Inc. Settles SEC Matter
01/06/2018
The Company Names New Chief Executive Officer, President and Board Member LAS VEGAS, June 01, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it [...]
SELLAS Life Sciences Provides Clinical Update on Phase 2b NeuVax™ (nelipepimut-S) Study in Combination with Trastuzumab in HER2 1+/2+ Breast Cancer Patients
01/06/2018
Phase 2b trial met key clinical objectives and is being discontinued early by the sponsor Clinical and regulatory meetings held at the American Society of Clinical Oncology (ASCO) conference Dr. Jeffrey S. Weber, [...]
Interpace Diagnostics Presents New Data on PancraGEN® at Digestive Disease Week
01/06/2018
WASHINGTON, June 01, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (the “Company” or “Interpace”), a fully integrated commercial and bioinformatics company that provides clinically useful [...]
LeMaitre Vascular to Present at the Jefferies Healthcare Conference on Friday, June 8, 2018
01/06/2018
BURLINGTON, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Friday, June [...]
Biotech with Liquid Biopsy for Colorectal Cancer Secures $26 Million in New Funding
01/06/2018
Clinical Genomics drives the commercialization of Colvera™, a liquid biopsy test service for colorectal cancer (CRC) recurrence and the focus of growing clinical evidence to support its use as the first widely adopted [...]
Imaging3 to Present at the 8th Annual LD Micro Invitational Conference
01/06/2018
BURBANK, Calif., June 01, 2018 (GLOBE NEWSWIRE) -- Imaging 3 , Inc. (OTCQB:IGNG), a development stage company introducing disruptive technologies in the medical imaging industry, has been invited to present at the 8th [...]
Maple Leaf Green World Inc. Engages Emerging Equities Inc. as its Strategic Financial Advisor in Connection and a Non-Brokered Private Placement
01/06/2018
CALGARY, Alberta, June 01, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (NEO:MGW) (OTCQB:MGWFF) is pleased to announce that it has entered into an agreement with Emerging [...]
Akcea and Ionis Receive Positive EU CHMP Opinion for TEGSEDI
01/06/2018
CAMBRIDGE, Mass. and CARLSBAD, Calif., June 01, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), announced [...]
Novan Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/06/2018
MORRISVILLE, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today reported that the Compensation Committee of Novan’s Board of Directors granted stock options to purchase an [...]
Genocea to Present at Jefferies 2018 Global Healthcare Conference
01/06/2018
Presentation to be webcast live at 12:30 pm ET on June 8, 2018 CAMBRIDGE, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer [...]

Pages